From this morning's Earlybird:

• "Former Rep. Billy Tauzin (R-La.) is stepping down as the head of the Pharmaceutical Research and Manufacturers of America (PhRMA)," The Hill reports. "Tauzin, 66, has been a major player on healthcare reform during the 111th Congress."

• "Congressional Democrats outlined legislation Thursday aimed at undoing a recent Supreme Court decision that allows corporations and interest groups to spend freely on political advertising," the New York Times reports.

• "Lobbying by insurers and banks including Morgan Stanley may eliminate a proposed new standard that would make retail brokers more accountable to their clients," Bloomberg News reports.